| Story Views | |
| Now: | |
| Last Hour: | |
| Last 24 Hours: | |
| Total: | |
VolitionRx appoints new finance head
Tuesday, April 11, 2017 6:49
% of readers think this story is Fact. Add your two cents.
Cancer diagnostics group VolitionRx Limited (NYSE MKT:VNRX) has appointed David Vanston as its new chief financial officer with immediate effect.
Vanston joins from Octo Telematics, a technology company based in Boston, where he was the Senior Controller for its US business.
Before this, he spent 20 years with globally-listed companies in a variety of sectors spanning manufacturing and technology to life sciences .
Cameron Reynolds, Volition’s chief executive, expressed confidence that Vanston would add value as VolitionRx becomes a revenue-generating company.
Former CFO David Kratochvil tendered his resignation in November, but stayed on until a successor was found.
Story by ProactiveInvestors
Source: http://www.proactiveinvestors.com/companies/news/176306/volitionrx-appoints-new-finance-head-176306.html
